ESMO Open: news in breast cancer 2019

بواسطة Lambertini, Matteo
الحاوية / القاعدة ESMO Open (2020)

ESMO Open special series on new emerging targets in cancer immunotherapy

بواسطة Lambertini, Matteo
الحاوية / القاعدة ESMO Open (2020)

Pregnancies in young women with diagnosis and treatment of HER2-positive breast cancer

بواسطة Lambertini, Matteo, Viglietti, Giulia
الحاوية / القاعدة Oncotarget (2019)

It Is Time to Talk About Fertility and Immunotherapy

بواسطة Duma, Narjust, Lambertini, Matteo
الحاوية / القاعدة Oncologist (2020)

Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

بواسطة Del Mastro, Lucia, Lambertini, Matteo
الحاوية / القاعدة Oncologist (2015)

The burden of breast cancer from China to Italy

بواسطة Levaggi, Alessia, Poggio, Francesca, Lambertini, Matteo
منشور في 2014

Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?

بواسطة Poggio, Francesca, Lambertini, Matteo, de Azambuja, Evandro
الحاوية / القاعدة ESMO Open (2018)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?

بواسطة Lambertini, Matteo, Viglietti, Giulia, de Azambuja, Evandro
الحاوية / القاعدة ESMO Open (2018)

How I treat metastatic triple-negative breast cancer

بواسطة Caparica, Rafael, Lambertini, Matteo, de Azambuja, Evandro
الحاوية / القاعدة ESMO Open (2019)

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series

بواسطة Lambertini, Matteo, Preusser, Matthias, Zielinski, Christoph C
الحاوية / القاعدة ESMO Open (2019)

Oncofertility and COVID-19—cancer does not wait

بواسطة Sirohi, Bhawna, Rohatgi, Tanya Buckshee, Lambertini, Matteo
الحاوية / القاعدة Ecancermedicalscience (2020)

Fertility issues in young breast cancer patients: what women want

بواسطة Lambertini, Matteo, Pinto, Ana Catarina, Del Mastro, Lucia
منشور في 2014

Twenty years of anti-HER2 therapy-associated cardiotoxicity

بواسطة Pondé, Noam F, Lambertini, Matteo, de Azambuja, Evandro
الحاوية / القاعدة ESMO Open (2016)

Oncofertility counselling in premenopausal women with HER2-positive breast cancer

بواسطة Lambertini, Matteo, Demeestere, Isabelle, Viglietti, Giulia, de Azambuja, Evandro
الحاوية / القاعدة Oncotarget (2019)

ESMO Leaders Generation Programme: an alumni insight

بواسطة Arruda, Leticia De Mattos, Criscitiello, Carmen, Lambertini, Matteo, Argiles, Guillem
الحاوية / القاعدة ESMO Open (2018)

Follow‐up strategies for women treated for early breast cancer

بواسطة Moschetti, Ivan, Cinquini, Michela, Lambertini, Matteo, Levaggi, Alessia, Liberati, Alessandro
الحاوية / القاعدة Cochrane Database Syst Rev (2016)

Highlights from the San Antonio Breast Cancer Symposium (SABCS) 2019

بواسطة Witzel, Isabell, Lambertini, Matteo, Balic, Marija, Wuerstlein, Rachel, Müller, Volkmar
الحاوية / القاعدة Breast Care (Basel) (2020)

Breast cancer screening of mutation carriers in the era of COVID‐19 pandemic

بواسطة Toss, Angela, Lambertini, Matteo, Punie, Kevin, Grandi, Giovanni, Cortesi, Laura
الحاوية / القاعدة Int J Cancer (2020)

Fertility counseling of young breast cancer patients

بواسطة Lambertini, Matteo, Anserini, Paola, Levaggi, Alessia, Poggio, Francesca, Del Mastro, Lucia
منشور في 2013

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?

بواسطة Lambertini, Matteo, Richard, François, Nguyen, Bastien, Viglietti, Giulia, Villarreal-Garza, Cynthia
الحاوية / القاعدة Clin Med Insights Reprod Health (2019)